Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer

Prior research suggests a link between circulating levels of follicle-stimulating hormone (FSH) and prostate cancer outcomes. FSH levels may also explain some of the observed differences in cardiovascular events among men treated with gonadotropin-releasing hormone (GnRH) antagonists compared to GnR...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourbanhoussen, Kassim, Joncas, France-Hélène, Wallis, Christopher JD, Hovington, Hélène, Dagenais, François, Fradet, Yves, Guillemette, Chantal, Lacombe, Louis, Toren, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788605/
https://www.ncbi.nlm.nih.gov/pubmed/34259197
http://dx.doi.org/10.4103/aja.aja_58_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788605/
https://www.ncbi.nlm.nih.gov/pubmed/34259197
http://dx.doi.org/10.4103/aja.aja_58_21

Ejemplares similares